5-Chlorosalicylic acid (CAS 321-14-2)
QUICK LINKS
5-Chlorosalicylic acid, also referred to as 5-chloro-2-hydroxybenzoic acid, is a synthetic compound widely utilized within the scientific community for various purposes. As an aromatic acid, it contains a benzene ring in its structure and falls under the category of phenolic acids. The compound appears as a white crystalline powder that readily dissolves in water and possesses a melting point of around 195°C. Its versatility has made it an indispensable component in numerous laboratory experiments and scientific research endeavors. This compound has found extensive application in diverse scientific research studies. Moreover, it has proven valuable in the synthesis of other compounds, including 5-Chlorosalicylic acidydroxybenzamide and 5-Chlorosalicylic acidydroxybenzoic anhydride. The mechanism of action of 5-Chlorosalicylic acid involves inhibiting the activity of enzymes known as cyclooxygenases (COX). 5-Chlorosalicylic acid holds an indispensable position in the scientific realm due to its multifaceted applications and its role in understanding cellular processes.
5-Chlorosalicylic acid (CAS 321-14-2) References
- Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation. | Diamantis, W., et al. 1978. Thromb Haemost. 40: 24-36. PMID: 103240
- Absorption, distribution, and metabolic fate of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one in rats, dogs, and humans. | Edelson, J., et al. 1975. J Pharm Sci. 64: 1316-21. PMID: 1097636
- Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats. | Sofia, RD., et al. 1975. J Pharm Sci. 64: 1321-4. PMID: 1151704
- Guest-controlling effects on ER behaviors of beta-cyclodextrin polymer. | Gao, ZW. and Zhao, XP. 2005. J Colloid Interface Sci. 289: 56-62. PMID: 16009217
- Mutagenic activity of 2-chloro-4-nitroaniline and 5-chlorosalicylic acid in Salmonella typhimurium: two possible metabolites of niclosamide. | Espinosa-Aguirre, JJ., et al. 1991. Mutat Res. 264: 139-45. PMID: 1944396
- Deciphering the photophysics of 5-chlorosalicylic acid: evidence for excited-state intramolecular proton transfer. | Paul, BK., et al. 2010. Photochem Photobiol Sci. 9: 57-67. PMID: 20062845
- Adsorption and transformation of the anthelmintic drug niclosamide by manganese oxide. | Tran, TH., et al. 2018. Chemosphere. 201: 425-431. PMID: 29529569
- Ligand-Controlled Regiodivergent Thiocarbonylation of Alkynes toward Linear and Branched α,β-Unsaturated Thioesters. | Ai, HJ., et al. 2021. Angew Chem Int Ed Engl. 60: 17178-17184. PMID: 34058046
- Salt formation, hydrogen-bonding patterns and supramolecular architectures of acridine with salicylic and hippuric acid molecules. | Suganya, S., et al. 2021. Acta Crystallogr C Struct Chem. 77: 790-799. PMID: 34864722
- Novel pharmaceutical salts of cephalexin with organic counterions: structural analysis and properties. | Hua, XN., et al. 2022. RSC Adv. 12: 34843-34850. PMID: 36540208
- [Bactericidal effect of streptomycin on acid-fast bacilli in the presence of 4-chloroanilid of 5-chlorosalicylic acid]. | Kostrzeński, W. and Paklerska-Pobratyn, H. 1973. Gruzlica. 41: 819-24. PMID: 4201979
- [Binding of 4-chloroanilide of 5-chlorosalicylic acid by blood serum proteins and other protein substances. I. Qualitative methods for determination of the binding of arylid by protein substances]. | Kostrzeński, W. and Paklerska-Pobratyn, H. 1970. Gruzlica. 38: 501-10. PMID: 5429202
- Structural studies on complexes. IV. Crystal structure of a 1:1 5-chlorosalicylic acid and theophylline complex. | Shefter, E. 1969. J Pharm Sci. 58: 710-4. PMID: 5799760
- Comparative antiphlogistic activity of meseclazone, 5-chlorosalicylic acid, acetylsalicylic acid, phenylbutazone, indomethacin and hydrocortisone in various rat paw edema models. | Sofia, RD. 1978. Pharmacology. 16: 148-52. PMID: 628674
- Comparative gastric ulcerogenic effects of meseclazone, 5-chlorosalicylic acid and other nonsteroidal anti-inflammatory drugs following acute and repeated oral administration to rats. | Diamantis, W., et al. 1980. Toxicol Appl Pharmacol. 52: 454-61. PMID: 6768168
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
5-Chlorosalicylic acid, 100 g | sc-239038 | 100 g | $22.00 |